Browsing: Drug pricing

Three progressive senators are asking why the Chamber of Commerce started a coalition earlier this year to oppose a White House rule that would allow it to use march-in rights to reduce drug costs. Democratic Sens. Elizabeth Warren (Mass.), Jeff Merkley (Oreg.) and Sen. Bernie Sanders want to know the reason.

Drugmaker AstraZeneca will cap out-of-pocket costs at $35 for all its inhaler products, the company announced Monday.  The cap is effective June 1 and will apply to the company’s entire range of inhaler products used to treat asthma and chronic obstructive pulmonary disease, including inhalers Symbicort, Breztri Aerosphere and Airsupra. The cap will be applicable for…